Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 92665-29-7
Drug Levels and Effects
Summary of Use during Lactation
Limited information indicates that cefprozil produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with cephalosporins, but these effects have not been adequately evaluated. Cefprozil is acceptable in nursing mothers.
Drug Levels
Maternal Levels. Nine healthy women were given a single 1 gram dose of cefprozil orally 6 to 12 months postpartum. Milk levels of cis-cefprozil (which accounts for 90% of cefprozil) ranged from 0.7 to 1.3 mg/L during the 12 hours after the dose. The peak level averaged 3.4 mg/L at 6 hours after the dose. By 24 hours after the dose, milk cefprozil levels were 0.3 mg/L.[1][2] Using the peak milk level value and assuming that the trans-isomer adds an additional 10% to the peak, an exclusively breastfed infant would receive a maximum of 3.3% of the weight-adjusted maternal dosage.
Infant Levels. Relevant published information was not found as of the revision date
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Shyu WC, Shah VR, Venitz J et al. The excretion of cefprozil (CPR) into breast milk. Clin Pharmacol Ther. 1992;51:182. Abstract. DOI: 10.1038/clpt.1992.14. [CrossRef]
- 2.
- Shyu WC, Shah VR, Campbell DA et al. Excretion of cefprozil into human breast milk. Antimicrob Agents Chemother. 1992;36:938-41. [PMC free article: PMC188771] [PubMed: 1510416]
Substance Identification
Substance Name
Cefprozil
CAS Registry Number
92665-29-7
Drug Class
- Breast Feeding
- Anti-Infective Agents
- Antibacterial Agents
- Cephalosporins
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Cefadroxil.[Drugs and Lactation Database (...]Review Cefadroxil.. Drugs and Lactation Database (LactMed®). 2006
- Review Ceftizoxime.[Drugs and Lactation Database (...]Review Ceftizoxime.. Drugs and Lactation Database (LactMed®). 2006
- Review Cefdinir.[Drugs and Lactation Database (...]Review Cefdinir.. Drugs and Lactation Database (LactMed®). 2006
- Review Ceftibuten.[Drugs and Lactation Database (...]Review Ceftibuten.. Drugs and Lactation Database (LactMed®). 2006
- Review Cefotaxime.[Drugs and Lactation Database (...]Review Cefotaxime.. Drugs and Lactation Database (LactMed®). 2006
- Cefprozil - Drugs and Lactation Database (LactMed®)Cefprozil - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...